Dulera

Dermatophytosis, Asthma, Itching + 14 more

Treatment

2 FDA approvals

20 Active Studies for Dulera

What is Dulera

Mometasone furoate

The Generic name of this drug

Treatment Summary

Mometasone furoate is a corticosteroid drug used to treat asthma, allergies, and certain skin conditions. It is much stronger than other corticosteroids, such as dexamethasone. Mometasone furoate is available as a dry powder inhaler, nasal spray, and ointment for different uses.

Elocon

is the brand name

image of different drug pills on a surface

Dulera Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Elocon

Mometasone furoate

1987

114

Approved as Treatment by the FDA

Mometasone furoate, also known as Elocon, is approved by the FDA for 2 uses including Asthma and Asthma .

Asthma

Helps manage Asthma

Asthma

Helps manage Asthma

Effectiveness

How Dulera Affects Patients

Mometasone is a synthetic steroid with an affinity for glucocorticoid receptors that is 22 times stronger than dexamethasone. It also has a lower affinity to mineralocorticoid receptors than natural corticosteroids, meaning it is more selective in how it works. After it is taken, mometasone passes through cell membranes and triggers pathways that reduce inflammation.

How Dulera works in the body

Mometasone targets inflammation in asthma by inhibiting cells and molecules that cause inflammation, like histamine and leukotrienes. It does this by binding to glucocorticoid receptors in cells. Mometasone has a particularly strong binding affinity compared to other corticosteroids. This binding causes a change in the receptor that lets it move to the nucleus, where it then binds to DNA and stops the expression of pro-inflammatory molecules. It also blocks transcription factors that cause inflammation.

When to interrupt dosage

The advised dose of Dulera is contingent upon the diagnosed condition, including Dermatitis, Eczematous brought on by superficial Fungal skin infection, Psoriasis and Skin Diseases, Eczematous. The quantity of dosage fluctuates in accordance with the method of delivery (e.g. Powder or Topical) featured in the table below.

Condition

Dosage

Administration

Dermatophytosis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Asthma

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Itching

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Atopic Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

prophylaxis of seasonal Allergic rhinitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Hay Fever

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Seasonal Allergies

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Skin Diseases, Eczematous

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Systemic Treatment

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Nasal Decongestants

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Bacterial Infections

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered, Inhalant - Respiratory (inhalation), Inhalant, Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Kit, Powder - Respiratory (inhalation), Powder, Spray, metered - Nasal, Capsule, Capsule - Respiratory (inhalation), Implant, Kit - Topical, Spray, Spray - Nasal

Warnings

Dulera has six contraindications, so it should be avoided if you have any of the conditions enumerated in the following table.

Dulera Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Mometasone Furoate may interact with Pulse Frequency

There are 20 known major drug interactions with Dulera.

Common Dulera Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Mometasone furoate.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be increased when combined with Mometasone furoate.

Aldesleukin

Major

The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.

Alectinib

Major

The metabolism of Alectinib can be increased when combined with Mometasone furoate.

Almotriptan

Major

The metabolism of Almotriptan can be decreased when combined with Mometasone furoate.

Dulera Toxicity & Overdose Risk

Overdosing on a mometasone furoate inhaler can cause an excessive amount of steroids in the body and may not require any extra treatment besides monitoring. Animal studies have shown that the maximum recommended human dose can have a negative effect on fetal development, so pregnant patients should consider the benefits and risks before use. It is unknown if the drug is passed through breast milk, so caution should be used when administering to nursing mothers. Clinical trials have proven the safety and effectiveness of mometasone furoate in pediatric patients, although growth may be reduced by 1cm per year depending on the dose and duration of treatment. Elder

image of a doctor in a lab doing drug, clinical research

Dulera Novel Uses: Which Conditions Have a Clinical Trial Featuring Dulera?

279 active trials are currently assessing the effectiveness of Dulera in alleviating Atopic Dermatitis, Seasonal Allergies and Psoriasis.

Condition

Clinical Trials

Trial Phases

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Dermatophytosis

0 Actively Recruiting

Systemic Treatment

0 Actively Recruiting

Seasonal Allergies

0 Actively Recruiting

Itching

4 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1

Hay Fever

0 Actively Recruiting

Skin Diseases, Eczematous

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

prophylaxis of seasonal Allergic rhinitis

0 Actively Recruiting

Dermatitis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Nasal Decongestants

8 Actively Recruiting

Early Phase 1, Phase 4, Not Applicable, Phase 3, Phase 2

Atopic Dermatitis

15 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Phase 1

Communicable Diseases

0 Actively Recruiting

Dulera Reviews: What are patients saying about Dulera?

5

Patient Review

12/26/2015

Dulera for Asthma

I had significant improvement in my breathing and lung capacity after using this product for just two days. I was able to sleep through the night without any issues and my blood oxygen level stayed steady even when I was working out.

5

Patient Review

4/15/2016

Dulera for Asthma

Dulera has completely changed my life for the better. I was very sick in 2015 and could barely walk to my car. My lung capacity was only 37%. I've been using Dulera for 4 months now and it's the only thing that has worked. I'm back at the gym and can finally sleep through the night. My rescue inhaler usage and other asthma medication have also decreased significantly. This medication has saved my life and I'm looking forward to traveling again soon.

5

Patient Review

4/29/2017

Dulera for Asthma

I had a chronic cough for years, and it really interfered with my quality of life. Once I was finally diagnosed with asthma, my doctor put me on Dulera. Within days, the coughing subsided significantly. The only downside is that I experience muscle cramps daily, but they're a small price to pay for being able to breathe easily again.

5

Patient Review

12/28/2016

Dulera for Bronchospasm Prevention with COPD

I've been using Dulera for six years now with no adverse effects. I'm quite pleased with the results and would recommend it to others, especially given that I'm on the older side.

5

Patient Review

4/13/2015

Dulera for Asthma

Dulera has been a game changer for me. I was constantly short of breath and using my rescue inhaler multiple times a day, but since switching to Dulera I haven't needed it once. Not only that, but I can now do more without feeling winded or needing a long "recovery" period afterwards.

4.7

Patient Review

5/5/2015

Dulera for Asthma

Dulera has been a game-changer for me. I've had asthma for 12 years and used many different inhalers and medications, which often resulted in hospital visits. Dulera has helped me to feel good and use my rescue medication less frequently.

4.7

Patient Review

5/28/2015

Dulera for Allergic Asthma

Dulera has worked very well for me and allowed me to breathe normally again. I do worry about the high cost though.

4

Patient Review

11/17/2019

Dulera for Bronchospasm Prevention with COPD

After trying many different inhalers with not-so-great side effects, Dulera has been the best for me by far.

4

Patient Review

10/29/2015

Dulera for Asthma

Helps a lot with dry mouth and thrush when used with a spacer. Much better than some of the other options out there.

3

Patient Review

6/1/2016

Dulera for Asthma

At first, this medication worked very well for me. However, after continued use I started feeling unwell. I experienced fatigue, weakness, and shaking, among other things. After doing some research, I realized that these were all potential side effects of the Dulera. I stopped taking it immediately and hope to start feeling better soon.

3

Patient Review

9/5/2019

Dulera for Asthma

I've been using this for four years without any issues, but recently I noticed that when I get to around 50 doses, it doesn't seem to work as well. Has anyone else had this problem?

3

Patient Review

4/2/2015

Dulera for Asthma

2.7

Patient Review

10/7/2015

Dulera for Asthma

I used Dulera for a month, at first I thought it was helping then the more I used it day after day it felt like my lungs were getting worse. I stopped Dulera a couple days ago and I'm waiting to see if my lungs improve.

1.3

Patient Review

9/13/2015

Dulera for Asthma

I took this medicine for almost two weeks and experienced terrible chest pain the whole time. I would never recommend it to anyone.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about dulera

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Dulera inhaler used for?

"DULERA is a prescription medicine that helps to control symptoms of asthma and prevent symptoms such as wheezing in people aged 5 years and older. It is not to be used to relieve sudden breathing problems, and will not replace the need for a rescue inhaler."

Answered by AI

Is Symbicort and Dulera the same thing?

"Dulera and Symbicort have the same bronchodilator ingredient. While Symbicort is FDA-approved to treat asthma and COPD, Dulera is only indicated for the treatment of asthma. In clinical studies, both medications have been found to be effective for asthma by improving quality of life and reducing asthma attacks."

Answered by AI

Is Dulera a steroid inhaler?

"DULERA is a combination of an inhaled corticosteroid medicine (ICS), mometasone furoate, and a long-acting beta 2-adrenergic agonist medicine (LABA), formoterol. It is used to relieve sudden breathing problems and will not replace a rescue inhaler."

Answered by AI

What is the difference between Advair and Dulera?

"Dulera is a medication that is used to treat asthma in adults and children who are at least five years old. It is sometimes prescribed for adults with COPD, even though it is not officially approved for this use. Advair is a medication that is used to treat asthma in adults and children who are at least four years old. It is also indicated to treat adults with COPD."

Answered by AI

Clinical Trials for Dulera

Image of Waianae Coast Comprehensive Health Center in Waianae, United States.

Community Program for Youth Well-Being

12 - 25
All Sexes
Waianae, HI

The goal of this pilot clinical trial is to learn if a community referral program can improve services for youth with mental health and chronic health conditions in a predominantly Native Hawaiian and Pacific Islander community. The main questions the trial aims to address are: * What is the best way for a community health center to connect youth with community programs rooted in cultural practices and traditions? * Does participation in community programs engage youth and mental health and chronic health outcomes? Participants will: * Participate in a community program for youth that will strengthen connection to 'āina (land) and culture. Programs in the summer are 5 hours per day, 4 days a week, for 4 weeks. Programs in the school-year are 2.5 hours per day, 2 days a week, for 16 weeks. * Take surveys on their demographics, general well-being, mental health, and chronic health conditions they may have at 4 different times: Before the program begins, immediately after the program finishes, 3-4 months after finishing, and 6-8 months after finishing. * Have an adult family member complete surveys on their youth's demographics and general well-being at the same 4 times

Recruiting
Has No Placebo

Waianae Coast Comprehensive Health Center

May M Okihrio, MD, MS

Have you considered Dulera clinical trials?

We made a collection of clinical trials featuring Dulera, we think they might fit your search criteria.
Go to Trials
Image of San Francisco VA Medical Center in San Francisco, United States.

Dietary Salt for Eczema

18+
All Sexes
San Francisco, CA

The goal of this clinical trial is to evaluate the feasibility of low-sodium diet to improve eczema severity. The main questions it aims to answer are: * Does a low-sodium diet improve eczema severity? * How does a low-sodium diet impact skin sodium concentration? * Is skin sodium concentration associated with eczema severity? Researchers will ask all participant to follow a low-sodium diet, then compare sodium tablets to a placebo (a look-alike substance that contains no drug) to specifically examine the impact of altering sodium intake. Participants will: * Follow a low-salt diet for the duration of the 24-week study * Take sodium chloride tablets every day for 5 weeks followed by a placebo every day for 5 weeks after a 2-week washout period, or vice versa * Complete up to 4 virtual check-in visits * Visit the clinic 4 times to answer questionnaires, provide bio samples, complete dietary recalls, and undergo non-contrast sodium MRI

Phase 4
Waitlist Available

San Francisco VA Medical Center (+1 Sites)

Katrina Abuabara, MD

Image of Corvus Clinical Trials in South San Francisco, United States.

Soquelitinib for Eczema

18+
All Sexes
South San Francisco, CA

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their AD changes during the study. The study doctors will see how safe soquelitinib is by tracking side effects among participants. They will also check "tolerability," which means how well the participants can handle soquelitinib and whether any potential side effects are manageable for them. To understand how well soquelitinib works, it will be compared with a placebo. Placebo is a substance that looks like soquelitinib but contains no active medicine in it. Participants will: * Take study treatment (soquelitinib or placebo) every day for 12 weeks * Visit the clinic for check-ups and tests every week for the first 2 weeks then every 2 weeks during the treatment period, and then return for follow-up visits 30, 60, and 90 days after the last dose of study treatment

Phase 2
Recruiting

Corvus Clinical Trials

Isin Sinem Bagci, MD

Corvus Pharmaceuticals, Inc.

Have you considered Dulera clinical trials?

We made a collection of clinical trials featuring Dulera, we think they might fit your search criteria.
Go to Trials
Image of Seeding Labs INC in Austin, United States.

Tailored Recommendations for Infant Gut Microbiome

No minimum age - 3
All Sexes
Austin, TX

The goal of this clinical trial is to learn whether microbiome analysis, education, and personalized recommendations can improve gut health and reduce early markers of immune-related conditions in infants aged 0-3 months delivered via Cesarean section. The study aims to determine whether these interventions can increase beneficial bacteria, decrease C-section-associated microbiome signatures, reduce opportunistic pathogens, and improve functional potential for HMO digestion and SCFA production. The study also seeks to assess whether improvements in microbiome composition are associated with a reduced prevalence of early atopic symptoms. Researchers will compare three groups: a full intervention arm that receives microbiome reports, coaching, personalized recommendations, and educational materials; a limited intervention arm that receives simplified reports and basic recommendations; and a control arm that receives no results until study completion. This design allows evaluation of both a comprehensive intervention and a more scalable, minimal-results model. Participants will: 1. Provide six microbiome stool samples over a 24-month period. 2. Provide additional small stool samples at two timepoints for exploratory metabolomic analysis. 3. Receive microbiome reports and guidance according to their assigned study arm. 4. Complete surveys on infant health history, symptoms, diet, and environmental exposures. 5. Participate in standardized eczema assessment(s) administered by a Nurse Practitioner and evaluated by a Pediatric Allergy Specialist if any symptoms are reported. This study seeks to demonstrate that targeted microbiome support can positively shift gut microbial development in C-section infants and may reduce risks linked to the early stages of the atopic march. Findings may inform scalable strategies for delivering microbiome-based support in early life and improve long-term health outcomes for this high-risk population.

Recruiting
Has No Placebo

Seeding Labs INC

Qian Yuan, MD

Seeding, Inc DBA Tiny Health

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Verified
Image of Velocity Clinical Research - Medford in Medford, United States.

ENV-294 for Asthma

18 - 75
All Sexes
Medford, OR

This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants will take oral ENV-294 or placebo once daily for 12 weeks. The study includes a screening period of up to 28 days before randomization to confirm eligibility. Study visits and assessments will be conducted to monitor safety, measure drug levels in the blood, and evaluate effects on asthma control and lung function.

Phase 2
Recruiting
Quick Reply

Velocity Clinical Research - Medford (+11 Sites)

Gurpreet Ahluwalia, PhD

Enveda Therapeutics

Have you considered Dulera clinical trials?

We made a collection of clinical trials featuring Dulera, we think they might fit your search criteria.
Go to Trials